- Home
- ANY vs BCTX Comparison
ANY vs BCTX Comparison
Compare ANY & BCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANY
- BCTX
- Stock Information
- Founded
- ANY N/A
- BCTX 2014
- Country
- ANY United States
- BCTX Canada
- Employees
- ANY N/A
- BCTX N/A
- Industry
- ANY Finance: Consumer Services
- BCTX Biotechnology: Pharmaceutical Preparations
- Sector
- ANY Finance
- BCTX Health Care
- Exchange
- ANY Nasdaq
- BCTX Nasdaq
- Market Cap
- ANY 16.4M
- BCTX 13.8M
- IPO Year
- ANY N/A
- BCTX N/A
- Fundamental
- Price
- ANY $0.65
- BCTX $7.87
- Analyst Decision
- ANY Strong Buy
- BCTX Strong Buy
- Analyst Count
- ANY 1
- BCTX 1
- Target Price
- ANY $3.00
- BCTX $40.00
- AVG Volume (30 Days)
- ANY 1.2M
- BCTX 89.2K
- Earning Date
- ANY 08-05-2025
- BCTX 10-28-2025
- Dividend Yield
- ANY N/A
- BCTX N/A
- EPS Growth
- ANY N/A
- BCTX N/A
- EPS
- ANY N/A
- BCTX N/A
- Revenue
- ANY $10,831,000.00
- BCTX N/A
- Revenue This Year
- ANY N/A
- BCTX N/A
- Revenue Next Year
- ANY $36.07
- BCTX N/A
- P/E Ratio
- ANY N/A
- BCTX N/A
- Revenue Growth
- ANY N/A
- BCTX N/A
- 52 Week Low
- ANY $0.36
- BCTX $6.00
- 52 Week High
- ANY $1.90
- BCTX $294.00
- Technical
- Relative Strength Index (RSI)
- ANY 57.60
- BCTX 42.07
- Support Level
- ANY $0.58
- BCTX $7.28
- Resistance Level
- ANY $0.66
- BCTX $8.82
- Average True Range (ATR)
- ANY 0.05
- BCTX 0.74
- MACD
- ANY 0.01
- BCTX 0.54
- Stochastic Oscillator
- ANY 91.72
- BCTX 66.13
About ANY Sphere 3D Corp.
Sphere 3D Corp provides solutions for stand-alone storage and technologies that converge the traditional silos of compute, storage, and network into integrated hyper-converged or converged solution. Its Disk systems include HVE Converged and Hyper-converged Infrastructure. It generates the majority of its revenue from the services it offers. All of its revenue comes from the Americas. The Company has two operating segments: Bitcoin Mining and Service and Product. The Bitcoin Mining segment generates revenue from the digital currency, it earns through its bitcoin mining activities. The Service and Product segment generates revenue from long-term customer contracts for service contracts and extended service contract and the sale of products related to the Company's data storage product line.
About BCTX BriaCell Therapeutics Corp.
BriaCell Therapeutics Corp is a clinical-stage immuno-oncology company. The group is developing an entirely new class of targeted immunotherapies to transform cancer care. Its product candidate Bria-IMT, is being evaluated in a pivotal Phase 3 combination study for metastatic breast cancer (MBC is breast cancer that has spread to other tissues). Bria-IMT is a targeted cell-based immunotherapy. The company is engaged in developing a Bria-OTS platform of personalized off-the-shelf cell-based immunotherapies. It is being evaluated in a Phase 1/2 clinical study and the treatment is initially focused on patients with breast cancer with an extension to prostate cancer, and other cancers.